Synchronized cycles of bacterial lysis for in vivo delivery
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The widespread view of bacteria as strictly pathogenic has given way to an appreciation of the prevalence of some beneficial microbes within the human body. It is perhaps inevitable that some bacteria would evolve to preferentially grow in environments that harbor disease and thus provide a natural platform for the development of engineered therapies. Such therapies could benefit from bacteria that are programmed to limit bacterial growth while continually producing and releasing cytotoxic agents in situ. Here we engineer a clinically relevant bacterium to lyse synchronously ata threshold population density and to release genetically encoded cargo. Following quorum lysis, a small number of surviving bacteria reseed the growing population, thus leading to pulsatile delivery cycles. We used microfluidic devices to characterize the engineered lysis strain and we demonstrate its potential as a drug delivery platform via co-culture with human cancer cells in vitro. Asa proof of principle, we tracked the bacterial population dynamics in ectopic syngeneic colorectal tumours in mice via a luminescent reporter. The lysis strain exhibits pulsatile population dynamics in vivo, with mean bacterial luminescence that remained two orders of magnitude lower than an unmodified strain. Finally, guided by previous findings that certain bacteria can enhance the efficacy of standard therapies, we orally administered the lysis strain alone or in combination with a clinical chemotherapeutic to a syngeneic mouse transplantation model of hepatic colorectal metastases. We found that the combination of both circuit-engineered bacteria and chemotherapy leads to a notable reduction of tumour activity along with a marked survival benefit over either therapy alone.Our approach establishes a methodology for leveraging the tools of synthetic biology to exploit the natural propensity for certain bacteria to colonize disease sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An interesting general approach implements engineered bacterial lysis, which enables antitumor protein production or release only when a predefined population density of bacteria is reached (154–157).”
From The microbiome and human cancer (2021) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
A synchronized quorum of genetic clocks
Danino, T., Mondragón-Palomino, O., Tsimring, L., & Hasty, J. (2010) · Nature · doi:10.1038/nature08753 · Cited by 992
Self-citationLeone, V., Gibbons, S. M., Martinez, K., Hutchison, A. L., Huang, E. Y., Cham, C. M., Pierre, J. F., Heneghan, A. F., Nadimpalli, A., Hubert, N., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.006 · Cited by 911
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905 · cited 1×
“Thus a synergistic effect may arise when bacteria are used to deliver drugs to the necrotic core of a tumor, while standard chemotherapy is used for the vascularized regions 11,26 .”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Microbial Dysbiosis Is Associated with Human Breast Cancer
Xuan, C., Shamonki, J. M., Chung, A., DiNome, M. L., Chung, M., Sieling, P. A., & Lee, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083744 · Cited by 543
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A., Kwong, G. A., Skalak, M., Li, H., Allen, K., Hasty, J., & Bhatia, S. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3519 · Cited by 467
Self-citation
Cited by
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
Self-citationGut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Chowdhury, S., Castro, S., Coker, C., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2019) · Nature Medicine · doi:10.1038/s41591-019-0498-z · Cited by 724
Self-citationEngineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Gurbatri, C. R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P. M., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0876 · Cited by 647
“Statistical analysis and sample sizes were determined from previous studies (21, 26, 45).”
BackgroundMethodInfluentialSelf-citationCullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K., & Elinav, E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.006 · Cited by 578
Choi, K. R., Jang, W. D., Yang, D., Cho, J. S., Park, D., & Lee, S. Y. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.01.003 · Cited by 566
Anticancer effects of the microbiome and its products
Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.44 · Cited by 538
Bacteria-cancer interactions: bacteria-based cancer therapy
Duong, M. T.-Q., Qin, Y., You, S.-H., & Min, J.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0297-0 · Cited by 519
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523
Hwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W. (2017) · Nature Communications · doi:10.1038/ncomms15028 · Cited by 472
Engineering bacteria for diagnostic and therapeutic applications
Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460
Engineering bacteria as interactive cancer therapies
Gurbatri, C. R., Arpaia, N., & Danino, T. (2022) · Science · doi:10.1126/science.add9667 · Cited by 447
Self-citationMedical Micro/Nanorobots in Precision Medicine
Soto, F., Wang, J., Ahmed, R., & Demirci, U. (2020) · Advanced Science · doi:10.1002/advs.202002203 · Cited by 442
Advances in Oral Drug Delivery Systems: Challenges and Opportunities
Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020484 · Cited by 397
Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts
Bourdeau, R. W., Lee-Gosselin, A., Lakshmanan, A., Farhadi, A., Kumar, S. R., Nety, S. P., & Shapiro, M. G. (2018) · Nature · doi:10.1038/nature25021 · Cited by 396
3D Printing of Living Responsive Materials and Devices
Liu, X., Yuk, H., Lin, S., Parada, G. A., Tang, T., Tham, E., de la Fuente‐Nunez, C., Lu, T. K., & Zhao, X. (2018) · Advanced Materials · doi:10.1002/adma.201704821 · Cited by 393
Bioengineered and biohybrid bacteria-based systems for drug delivery
Hosseinidoust, Z., Mostaghaci, B., Yasa, O., Park, B.-W., Singh, A. V., & Sitti, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.09.007 · Cited by 368
Fan, J., Peng, M., Wang, H., Zheng, H., Liu, Z., Li, C., Wang, X., Liu, X., Cheng, S., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201808278 · Cited by 363
Engineering living therapeutics with synthetic biology
Cubillos-Ruiz, A., Guo, T., Sokolovska, A., Miller, P. F., Collins, J. J., Lu, T. K., & Lora, J. M. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00285-3 · Cited by 356
Optically-controlled bacterial metabolite for cancer therapy
Zheng, D.-W., Chen, Y., Li, Z.-H., Xu, L., Li, C.-X., Li, B., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03233-9 · Cited by 324
Bacteria‐Based Cancer Immunotherapy
Huang, X., Pan, J., Xu, F., Shao, B., Wang, Y., Guo, X., & Zhou, S. (2021) · Advanced Science · doi:10.1002/advs.202003572 · Cited by 304
Recent progress in fluorescent probes for bacteria
Huang, Y., Chen, W., Chung, J., Yin, J., & Yoon, J. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01340d · Cited by 299
Akolpoglu, M. B., Alapan, Y., Dogan, N. O., Baltaci, S. F., Yasa, O., Aybar Tural, G., & Sitti, M. (2022) · Science Advances · doi:10.1126/sciadv.abo6163 · Cited by 293
Designing cell function: assembly of synthetic gene circuits for cell biology applications
Xie, M., & Fussenegger, M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0024-z · Cited by 285
Probiotic-guided CAR-T cells for solid tumor targeting
Vincent, R. L., Gurbatri, C. R., Li, F., Vardoshvili, A., Coker, C., Im, J., Ballister, E. R., Rouanne, M., Savage, T., de los Santos-Alexis, K., et al. (2023) · Science · doi:10.1126/science.add7034 · Cited by 273
Self-citationYue, Y., Xu, J., Li, Y., Cheng, K., Feng, Q., Ma, X., Ma, N., Zhang, T., Wang, X., Zhao, X., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00886-2 · Cited by 264
Fan, J.-X., Li, Z.-H., Liu, X.-H., Zheng, D.-W., Chen, Y., & Zhang, X.-Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05323 · Cited by 264
A programmable encapsulation system improves delivery of therapeutic bacteria in mice
Harimoto, T., Hahn, J., Chen, Y.-Y., Im, J., Zhang, J., Hou, N., Li, F., Coker, C., Gray, K., Harr, N., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01244-y · Cited by 260
Self-citationHydrogel-based biocontainment of bacteria for continuous sensing and computation
Tang, T.-C., Tham, E., Liu, X., Yehl, K., Rovner, A. J., Yuk, H., de la Fuente-Nunez, C., Isaacs, F. J., Zhao, X., & Lu, T. K. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00779-6 · Cited by 258
Engineered Living Materials For Sustainability
An, B., Wang, Y., Huang, Y., Wang, X., Liu, Y., Xun, D., Church, G. M., Dai, Z., Yi, X., Tang, T.-C., et al. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00512 · Cited by 252
Ma, X., Liang, X., Li, Y., Feng, Q., Cheng, K., Ma, N., Zhu, F., Guo, X., Yue, Y., Liu, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37225-1 · Cited by 243
Li, Z., Wang, Y., Liu, J., Rawding, P., Bu, J., Hong, S., & Hu, Q. (2021) · Advanced Materials · doi:10.1002/adma.202102580 · Cited by 244
Abouelela, M. E., & Helmy, Y. A. (2024) · Microorganisms · doi:10.3390/microorganisms12030430 · Cited by 238
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230
Chen, F., Zang, Z., Chen, Z., Cui, L., Chang, Z., Ma, A., Yin, T., Liang, R., Han, Y., Wu, Z., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119226 · Cited by 218
Microbiota in Tumors: From Understanding to Application
Xie, Y., Xie, F., Zhou, X., Zhang, L., Yang, B., Huang, J., Wang, F., Yan, H., Zeng, L., Zhang, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202200470 · Cited by 209
Synthetic biomarkers: a twenty-first century path to early cancer detection
Kwong, G. A., Ghosh, S., Gamboa, L., Patriotis, C., Srivastava, S., & Bhatia, S. N. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00389-3 · Cited by 209
Self-citationEngineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
Gurbatri, C. R., Radford, G. A., Vrbanac, L., Im, J., Thomas, E. M., Coker, C., Taylor, S. R., Jang, Y., Sivan, A., Rhee, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44776-4 · Cited by 199
Self-citationExploiting bacteria for cancer immunotherapy
Kwon, S.-Y., Thi-Thu Ngo, H., Son, J., Hong, Y., & Min, J.-J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00908-9 · Cited by 201
Synthetic Biology—The Synthesis of Biology
Ausländer, S., Ausländer, D., & Fussenegger, M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201609229 · Cited by 206
Chen, Y., Du, M., Yuan, Z., Chen, Z., & Yan, F. (2022) · Nature Communications · doi:10.1038/s41467-022-31932-x · Cited by 189
Quorum sensing for population-level control of bacteria and potential therapeutic applications
Wu, S., Liu, J., Liu, C., Yang, A., & Qiao, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03326-8 · Cited by 189
Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox
Pedrolli, D. B., Ribeiro, N. V., Squizato, P. N., de Jesus, V. N., Cozetto, D. A., Tuma, R. B., Gracindo, A., Cesar, M. B., Freire, P. J. C., da Costa, A. F. M., et al. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.09.005 · Cited by 189
Applications of synthetic biology in medical and pharmaceutical fields
Yan, X., Liu, X., Zhao, C., & Chen, G.-Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01440-5 · Cited by 179
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Li, Z., Xiong, W., Liang, Z., Wang, J., Zeng, Z., Kołat, D., Li, X., Zhou, D., Xu, X., & Zhao, L. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01541-w · Cited by 176
A stabilized microbial ecosystem of self-limiting bacteria using synthetic quorum-regulated lysis
Scott, S. R., Din, M. O., Bittihn, P., Xiong, L., Tsimring, L. S., & Hasty, J. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.83 · Cited by 173
Self-citationDNA-based memory devices for recording cellular events
Sheth, R. U., & Wang, H. H. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0052-8 · Cited by 172
White paper on microbial anti-cancer therapy and prevention
Forbes, N. S., Coffin, R. S., Deng, L., Evgin, L., Fiering, S., Giacalone, M., Gravekamp, C., Gulley, J. L., Gunn, H., Hoffman, R. M., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0381-3 · Cited by 168
Enhancing the tropism of bacteria via genetically programmed biosensors
Chien, T., Harimoto, T., Kepecs, B., Gray, K., Coker, C., Hou, N., Pu, K., Azad, T., Nolasco, A., Pavlicova, M., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00772-3 · Cited by 164
Self-citationAn Automated Model Test System for Systematic Development and Improvement of Gene Expression Models
Reis, A. C., & Salis, H. M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00394 · Cited by 166
Biohybrid Microtube Swimmers Driven by Single Captured Bacteria
Stanton, M. M., Park, B., Miguel‐López, A., Ma, X., Sitti, M., & Sánchez, S. (2017) · Small · doi:10.1002/smll.201603679 · Cited by 166
Acoustically triggered mechanotherapy using genetically encoded gas vesicles
Bar-Zion, A., Nourmahnad, A., Mittelstein, D. R., Shivaei, S., Yoo, S., Buss, M. T., Hurt, R. C., Malounda, D., Abedi, M. H., Lee-Gosselin, A., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00971-8 · Cited by 166
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
Savage, T. M., Vincent, R. L., Rae, S. S., Huang, L. H., Ahn, A., Pu, K., Li, F., de los Santos-Alexis, K., Coker, C., Danino, T., et al. (2023) · Science Advances · doi:10.1126/sciadv.adc9436 · Cited by 161
Self-citationRock-paper-scissors: Engineered population dynamics increase genetic stability
Liao, M. J., Din, M. O., Tsimring, L., & Hasty, J. (2019) · Science · doi:10.1126/science.aaw0542 · Cited by 160
Self-citationSynthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity
Ozdemir, T., Fedorec, A. J. H., Danino, T., & Barnes, C. P. (2018) · Cell Systems · doi:10.1016/j.cels.2018.06.008 · Cited by 159
Self-citationTweak to Treat: Reprograming Bacteria for Cancer Treatment
Sieow, B. F.-L., Wun, K. S., Yong, W. P., Hwang, I. Y., & Chang, M. W. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.11.004 · Cited by 158
An Active Approach to Colloidal Self-Assembly
Mallory, S. A., Valeriani, C., & Cacciuto, A. (2017) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-050317-021237 · Cited by 175
Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy
Liang, K., Liu, Q., Li, P., Luo, H., Wang, H., & Kong, Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.037 · Cited by 154
Bacteria as genetically programmable producers of bioactive natural products
Hug, J. J., Krug, D., & Müller, R. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0176-1 · Cited by 167
Anaerobe‐Inspired Anticancer Nanovesicles
Qian, C., Feng, P., Yu, J., Chen, Y., Hu, Q., Sun, W., Xiao, X., Hu, X., Bellotti, A., Shen, Q., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611783 · Cited by 149
Bioengineering of bacteria for cancer immunotherapy
Nguyen, D.-H., Chong, A., Hong, Y., & Min, J. (2023) · Nature Communications · doi:10.1038/s41467-023-39224-8 · Cited by 169
Droplet microfluidics for synthetic biology
Gach, P. C., Iwai, K., Kim, P. W., Hillson, N. J., & Singh, A. K. (2017) · Lab on a Chip · doi:10.1039/c7lc00576h · Cited by 143
Soto, F., & Chrostowski, R. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00170 · Cited by 142
Synthetic gene circuits for the detection, elimination and prevention of disease
Sedlmayer, F., Aubel, D., & Fussenegger, M. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0215-0 · Cited by 151
Sequential Magneto‐Actuated and Optics‐Triggered Biomicrorobots for Targeted Cancer Therapy
Xing, J., Yin, T., Li, S., Xu, T., Ma, A.-Q., Chen, Z., Luo, Y., Lai, Z., Lv, Y., Pan, H., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202008262 · Cited by 139
The bacterial cell cycle, chromosome inheritance and cell growth.
Reyes-Lamothe, R., & Sherratt, D. J. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0212-7 · Cited by 131
Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Bae, S., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Kansra, V. V., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.007 · Cited by 139
Game changers in science and technology - now and beyond
Betz, U. A. K., Arora, L., Assal, R. A., de Azevedo, H. F. Z., Baldwin, J., Becker, M. S., Bostock, S., Cheng, V. W. T., Egle, T., Ferrari, N., et al. (2023) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2023.122588 · Cited by 175
Deep reinforcement learning for the control of microbial co-cultures in bioreactors
Treloar, N. J., Fedorec, A. J. H., Ingalls, B., & Barnes, C. P. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007783 · Cited by 130
Synthetic Biology for Manipulating Quorum Sensing in Microbial Consortia
Stephens, K., & Bentley, W. E. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.009 · Cited by 126
Theranostic cells: emerging clinical applications of synthetic biology
McNerney, M. P., Doiron, K. E., Ng, T. L., Chang, T. Z., & Silver, P. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00383-3 · Cited by 141
Hurt, R. C., Buss, M. T., Duan, M., Wong, K., You, M. Y., Sawyer, D. P., Swift, M., Dutka, P., Barturen‐Larrea, P., Mittelstein, D. R., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01581-y · Cited by 137
Stimuli-responsive engineered living materials
Rivera‐Tarazona, L. K., Campbell, Z. T., & Ware, T. H. (2021) · Soft Matter · doi:10.1039/d0sm01905d · Cited by 139
Biohybrid robots: recent progress, challenges, and perspectives
Webster‐Wood, V. A., Guix, M., Xu, N. W., Behkam, B., Sato, H., Sarkar, D., Sánchez, S., Shimizu, M., & Parker, K. K. (2022) · Bioinspiration & Biomimetics · doi:10.1088/1748-3190/ac9c3b · Cited by 168
Designer probiotics for the prevention and treatment of human diseases
Chua, K. J., Kwok, W. C., Aggarwal, N., Sun, T., & Chang, M. W. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.04.011 · Cited by 137
Progress of engineered bacteria for tumor therapy
Fan, J.-X., Niu, M.-T., Qin, Y.-T., Sun, Y.-X., & Zhang, X.-Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114296 · Cited by 120
Programmable assembly of pressure sensors using pattern-forming bacteria
Cao, Y., Feng, Y., Ryser, M. D., Zhu, K., Herschlag, G., Cao, C. C., Marusak, K. E., Zauscher, S., & You, L. (2017) · Nature Biotechnology · doi:10.1038/nbt.3978 · Cited by 126
Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy
Neubi, G. M. N., Opoku‐Damoah, Y., Gu, X., Han, Y., Zhou, J., & Ding, Y. (2018) · Biomaterials Science · doi:10.1039/c8bm00175h · Cited by 126
Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron
Taketani, M., Zhang, J., Zhang, S., Triassi, A. J., Huang, Y.-J., Griffith, L. G., & Voigt, C. A. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0468-5 · Cited by 124
Bacterial therapies at the interface of synthetic biology and nanomedicine
Hahn, J., Ding, S., Im, J., Harimoto, T., Leong, K. W., & Danino, T. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00119-4 · Cited by 139
Self-citationPlant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems
Malekzad, H., Mirshekari, H., Zangabad, P. S., Basri, S. M. M., Baniasadi, F., Aghdam, M. S., Karimi, M., & Hamblin, M. R. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2017.1312267 · Cited by 116
Roads to Smart Artificial Microswimmers
Tsang, A. C. H., Demir, E., Ding, Y., & Pak, O. S. (2020) · Advanced Intelligent Systems · doi:10.1002/aisy.201900137 · Cited by 126
Zheng, D., Pan, P., Chen, K.-W., Fan, J., Li, C., Cheng, H. L., & Zhang, X. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0582-1 · Cited by 115
Chang, Z., Guo, X., Li, X., Wang, Y., Zang, Z., Pei, S., Lu, W., Li, Y., Huang, J., Xiao, Y., et al. (2025) · Cell · doi:10.1016/j.cell.2025.02.002 · Cited by 129
The art of vector engineering: towards the construction of next‐generation genetic tools
Nora, L. C., Westmann, C. A., Martins‐Santana, L., Alves, L. D. F., Monteiro, L. M. O., Guazzaroni, M., & Silva‐Rocha, R. (2018) · Microbial Biotechnology · doi:10.1111/1751-7915.13318 · Cited by 122
Customized materials-assisted microorganisms in tumor therapeutics
Chen, Q., Qiao, J., Liu, X., Zhang, C., & Zhang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01571g · Cited by 110
Advances in bacterial cancer therapies using synthetic biology
Chien, T., Doshi, A., & Danino, T. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.009 · Cited by 119
Self-citationBioinspired oral delivery devices
Zhang, X., Chen, G., Zhang, H., Shang, L., & Zhao, Y. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00006-4 · Cited by 120
Ha, J.-H., Hauk, P., Cho, K., Eo, Y., Ma, X., Stephens, K., Cha, S., Jeong, M., Suh, J.-Y., Sintim, H. O., et al. (2018) · Science Advances · doi:10.1126/sciadv.aar7063 · Cited by 104
Quorum Sensing Communication: Molecularly Connecting Cells, Their Neighbors, and Even Devices
Wang, S., Payne, G. F., & Bentley, W. E. (2020) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-101519-124728 · Cited by 110
Harnessing Protease Activity to Improve Cancer Care
Dudani, J. S., Warren, A., & Bhatia, S. N. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050549 · Cited by 107
Self-citationBacteria and bacterial derivatives as delivery carriers for immunotherapy
Kang, S., Nguyen, D.-H., Yoo, S. W., & Min, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114085 · Cited by 106
Oral delivery of bacteria: Basic principles and biomedical applications
Li, S., Jiang, W., Zheng, C., Shao, D., Liu, Y., Huang, S., Han, J., Ding, J., Tao, Y., & Li, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.011 · Cited by 97
Agent-based modelling in synthetic biology
Gorochowski, T. E. (2016) · Essays in Biochemistry · doi:10.1042/ebc20160037 · Cited by 86
Rational engineering of synthetic microbial systems: from single cells to consortia
Bittihn, P., Din, M. O., Tsimring, L. S., & Hasty, J. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.009 · Cited by 91
Self-citationMethods and Applications of Mobile Molecular Communication
Nakano, T., Okaie, Y., Kobayashi, S., Hara, T., Hiraoka, Y., & Haraguchi, T. (2019) · Proceedings of the IEEE · doi:10.1109/jproc.2019.2917625 · Cited by 103
The impact of the intestinal microbiota in therapeutic responses against cancer
Goubet, A., Daillère, R., Routy, B., Derosa, L., Roberti, P. M., & Zitvogel, L. (2018) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2018.03.004 · Cited by 100
Emerging Opportunities for Synthetic Biology in Agriculture
Goold, H. D., Wright, P., & Hailstones, D. (2018) · Genes · doi:10.3390/genes9070341 · Cited by 106
Metadata
- Authors
- Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., & Hasty, J.
- Affiliations
- University of California San Diego (US)
- Massachusetts Institute of Technology (US)
- Broad Institute (US)
- Corresponding author
- Hasty, Jeff
- ORCID
- Venue
- Nature
- Published
- 2016-07-20
- Volume
- 536
- Issue
- 7614
- Pages
- 81-85
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5048415
- OpenAlex
- W2480697384
- Cited by
- 784
- References
- 31
- Citations by year
- 2026: 97 · 2025: 107 · 2024: 95 · 2023: 87 · 2022: 73 · 2021: 71 · 2020: 82 · 2019: 59 · 2018: 55 · 2017: 43 · 2016: 12
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- PMC
- Funders
- Howard Hughes Medical Institute
- University of California, San Diego
- National Cancer Institute (K99CA197649, R00CA197649, DP1CA174420, P30CA014051)
- National Institute of General Medical Sciences (P50GM085764, R01GM069811)
- National Institute of Environmental Health Sciences (P30ES002109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial lysis, quorum sensing, synthetic biology, Salmonella, pulsatile drug delivery, cancer therapy, colorectal cancer, liver metastasis, bacterial population dynamics, luminescent reporter, combination chemotherapy, oral administration, living therapeutics
- MeSH terms
- Administration, Oral, Animals, Bacteriolysis, Computer Simulation, Female, Liver Neoplasms, Neoplasm Metastasis, Neoplasm Transplantation, Salmonella, Transplantation, Isogeneic, Colorectal Neoplasms, Drug Delivery Systems, Coculture Techniques, Luminescence, Mice, Quorum Sensing, Synthetic Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.